Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early Study

기사 요약

Forte Biosciences reported positive Phase 1b vitiligo data, with FB102 showing significant facial repigmentation and favorable safety.